Design of Ni-oxide Nanocomposites Containing 13-Retinoic Acid and Cholecalciferol Compounds and their Cytotoxicity on CP70 and Mice

Ovarian cancer is the most common cause of female death due to genital cancers and five causes of cancer death in women. The results of this study show that NiO nanoparticles can be prepared with homogeneity and suitable size for different applications. The study also shows the ability of NiO nanoparticles to supply D3 and A vitamins. Samples were also evaluated by XRD and FTIR techniques. NiO nanostructured crystals, nickel oxide bound to vitamin D (total calciferol) and NiO, bound to vitamin A (retinoic acid) were estimated by the Debye-Sherrer ratio of 13, 98 and 170 nm. Then, CP70 ovarian cancer cells In 5% CO2 and 37°C, cells were cultured with nickel oxide nanoparticles, vitamins A and prepared at different concentrations, as well as nanoparticles containing these vitamins at different levels of 24, 48, 72 and 96 hours were affected. According to the results of MTT, 10 and 25% vitamins treatments were single or attached to NiO nanoparticles at treatment time of 72 and 96 hours (p<0.001). Finally, induction of cancer in mice was done by injection of CP70 and after 4 weeks the mice were prepared. Treatment of mice by NiO treatment groups attached to vitamin A, NiO bound to vitamin D, vitamin A alone, and vitamin D was performed. Meanwhile, two control groups: negative (healthy and untreated) and positive (non-treated) mice were tested. The diseased and healthy tissues of the rats were determined by describing the results and analyzing the chromosomal chromosome-eosin staining. The results of the present study indicate that the interaction groups of nickel oxide nanoparticles containing vitamins A and D can produce significant cellular effects on blood cells and cause significant growth in these cells. The bioavailability of vitamins A and D can be effective in the treatment of ovarian cancer.

The method for producing nickel oxide nanoparticles is as follows: First, metal ions react with a suitable quenching factor and form a complex solution in which there is a precipitating agent. Then the complex separates to release metal ions. This is done through solvent conditions such as concentration or temperature. In this experiment, ammonia was selected as a quenching agent and nickel nitrate as a source of Ni2+. Initially, a solution of the nickel hexa-amine complex is formed, then the complex proceeds by separating the solution by diluting the solution with water. The solution is also heated to remove ammonia from the aqueous solution. The concentration of ammonia in the solution decreases and the free ion of nickel increases. When the concentration of free ions reaches a certain amount of nickel hydroxide it is uniformly obtained in solution. The resulting nickel oxide nanoparticles have a high efficiency and purity, a process that is inexpensive, fast and producible for the synthesis of nickel oxide nanoparticles, as well as nano-carriers of vitamin A and D3 are suitable in large quantities.

DOI: 10.36648/endocrinology-metabolism.4.4.3

Endocrinology and Metabolism: Open Access is a peer reviewed journal which focuses on the publication of current research and developments on the endocrine glands and its secretions with their coordination with metabolism and reproduction. Endocrinology and Metabolism: Open Access Journal is using Editorial Tracking System to maintain quality and transparency to the author in the peer-review process. Review processing will be performed by the editorial board members of the Journal Endocrinology and Metabolism: Open Access or by Reviewers (outside experts in the field). Two independent reviewer’s approval (Minimum reviewer’s approval) followed by editor approval is obligatory for acceptance of any manuscript excluding an editorial.

Submit your manuscript at: https://www.imedpub.com/submissions/endocrinology-metabolism-open-access.html

Send as an attachment to mail endometabol@emedscholar.com

Media Contact
Eliza Grace
Associate Managing Editor
Endocrinology and Metabolism: Open Access
E-Mail: endometabol@emedscholar.com